Published in Medical Device Business Week, September 29th, 2004
"We are pleased to be working again with Stockgroup. Our information distribution program with Stockgroup earlier this year was very effective for the company and our investors," said Robert Rieveley, the president of Biotech.
"The launch of Sucanon in Mexico next month, filing of regulatory applications in other countries in Latin America and our plans to make Sucanon available to diabetics in the U.S. through Mexican pharmacies, will mean that the next 3 months will be a very active period with a regular flow of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week